Submit Deal

QUINCE THERAPEUTICS

Summary

Quince Therapeutics is a biotechnology company that focuses on acquiring, developing, and commercializing therapeutics.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 492 M

Avg. Deal Size£ 246 M

Market Context

Senior Management

Sort

erydel

HQ - Italy

Biotechnology

23 Oct 2023

Investment Date

100%

Stake

£ 419 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management